nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifaximin—NR1I2—Nuclear Receptors—THRA—hypothyroidism	0.0528	0.264	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.0417	0.208	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptors—THRB—hypothyroidism	0.034	0.17	CbGpPWpGaD
Rifaximin—Swelling face—Liotrix—hypothyroidism	0.0335	0.0419	CcSEcCtD
Rifaximin—NR1I2—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.0269	0.134	CbGpPWpGaD
Rifaximin—Cellulitis—Liotrix—hypothyroidism	0.0176	0.022	CcSEcCtD
Rifaximin—Hypoglycaemia—Dextrothyroxine—hypothyroidism	0.0161	0.0202	CcSEcCtD
Rifaximin—Hypoglycaemia—Levothyroxine—hypothyroidism	0.0161	0.0202	CcSEcCtD
Rifaximin—Fluid retention—Liotrix—hypothyroidism	0.0152	0.019	CcSEcCtD
Rifaximin—Hypotension—Liothyronine—hypothyroidism	0.0147	0.0184	CcSEcCtD
Rifaximin—Dehydration—Levothyroxine—hypothyroidism	0.0147	0.0183	CcSEcCtD
Rifaximin—Dehydration—Dextrothyroxine—hypothyroidism	0.0147	0.0183	CcSEcCtD
Rifaximin—Dysphagia—Levothyroxine—hypothyroidism	0.0136	0.017	CcSEcCtD
Rifaximin—Dysphagia—Dextrothyroxine—hypothyroidism	0.0136	0.017	CcSEcCtD
Rifaximin—Sweating increased—Dextrothyroxine—hypothyroidism	0.0133	0.0166	CcSEcCtD
Rifaximin—Sweating increased—Levothyroxine—hypothyroidism	0.0133	0.0166	CcSEcCtD
Rifaximin—Body temperature increased—Liothyronine—hypothyroidism	0.0125	0.0156	CcSEcCtD
Rifaximin—Weight decreased—Levothyroxine—hypothyroidism	0.0123	0.0154	CcSEcCtD
Rifaximin—Weight decreased—Dextrothyroxine—hypothyroidism	0.0123	0.0154	CcSEcCtD
Rifaximin—Hypoglycaemia—Liotrix—hypothyroidism	0.0119	0.0149	CcSEcCtD
Rifaximin—NR1I2—Generic Transcription Pathway—ZNF764—hypothyroidism	0.0112	0.0559	CbGpPWpGaD
Rifaximin—Dehydration—Liotrix—hypothyroidism	0.0108	0.0135	CcSEcCtD
Rifaximin—Flushing—Levothyroxine—hypothyroidism	0.0101	0.0126	CcSEcCtD
Rifaximin—Flushing—Dextrothyroxine—hypothyroidism	0.0101	0.0126	CcSEcCtD
Rifaximin—Abdominal distension—Liotrix—hypothyroidism	0.0101	0.0126	CcSEcCtD
Rifaximin—Dysphagia—Liotrix—hypothyroidism	0.01	0.0125	CcSEcCtD
Rifaximin—Sweating increased—Liotrix—hypothyroidism	0.00976	0.0122	CcSEcCtD
Rifaximin—Weight decreased—Liotrix—hypothyroidism	0.00906	0.0113	CcSEcCtD
Rifaximin—Tremor—Dextrothyroxine—hypothyroidism	0.00889	0.0111	CcSEcCtD
Rifaximin—Tremor—Levothyroxine—hypothyroidism	0.00889	0.0111	CcSEcCtD
Rifaximin—Angioedema—Dextrothyroxine—hypothyroidism	0.00867	0.0108	CcSEcCtD
Rifaximin—Angioedema—Levothyroxine—hypothyroidism	0.00867	0.0108	CcSEcCtD
Rifaximin—Arthralgia—Levothyroxine—hypothyroidism	0.00808	0.0101	CcSEcCtD
Rifaximin—Arthralgia—Dextrothyroxine—hypothyroidism	0.00808	0.0101	CcSEcCtD
Rifaximin—Hypoaesthesia—Liotrix—hypothyroidism	0.00798	0.00998	CcSEcCtD
Rifaximin—Confusional state—Dextrothyroxine—hypothyroidism	0.00781	0.00976	CcSEcCtD
Rifaximin—Confusional state—Levothyroxine—hypothyroidism	0.00781	0.00976	CcSEcCtD
Rifaximin—Shock—Levothyroxine—hypothyroidism	0.00762	0.00953	CcSEcCtD
Rifaximin—Shock—Dextrothyroxine—hypothyroidism	0.00762	0.00953	CcSEcCtD
Rifaximin—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00749	0.00936	CcSEcCtD
Rifaximin—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00749	0.00936	CcSEcCtD
Rifaximin—Flushing—Liotrix—hypothyroidism	0.00744	0.0093	CcSEcCtD
Rifaximin—NR1I2—Generic Transcription Pathway—THRA—hypothyroidism	0.00721	0.036	CbGpPWpGaD
Rifaximin—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00706	0.00882	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00706	0.00882	CcSEcCtD
Rifaximin—Insomnia—Levothyroxine—hypothyroidism	0.00701	0.00876	CcSEcCtD
Rifaximin—Insomnia—Dextrothyroxine—hypothyroidism	0.00701	0.00876	CcSEcCtD
Rifaximin—Dyspnoea—Levothyroxine—hypothyroidism	0.00691	0.00863	CcSEcCtD
Rifaximin—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00691	0.00863	CcSEcCtD
Rifaximin—Flatulence—Liotrix—hypothyroidism	0.00688	0.0086	CcSEcCtD
Rifaximin—Fatigue—Levothyroxine—hypothyroidism	0.00668	0.00835	CcSEcCtD
Rifaximin—Fatigue—Dextrothyroxine—hypothyroidism	0.00668	0.00835	CcSEcCtD
Rifaximin—Tremor—Liotrix—hypothyroidism	0.00654	0.00818	CcSEcCtD
Rifaximin—Feeling abnormal—Levothyroxine—hypothyroidism	0.00638	0.00798	CcSEcCtD
Rifaximin—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00638	0.00798	CcSEcCtD
Rifaximin—Angioedema—Liotrix—hypothyroidism	0.00638	0.00797	CcSEcCtD
Rifaximin—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00633	0.00792	CcSEcCtD
Rifaximin—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00633	0.00792	CcSEcCtD
Rifaximin—Syncope—Liotrix—hypothyroidism	0.00626	0.00783	CcSEcCtD
Rifaximin—Urticaria—Dextrothyroxine—hypothyroidism	0.00615	0.00769	CcSEcCtD
Rifaximin—Urticaria—Levothyroxine—hypothyroidism	0.00615	0.00769	CcSEcCtD
Rifaximin—Loss of consciousness—Liotrix—hypothyroidism	0.00614	0.00767	CcSEcCtD
Rifaximin—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00612	0.00766	CcSEcCtD
Rifaximin—Abdominal pain—Levothyroxine—hypothyroidism	0.00612	0.00766	CcSEcCtD
Rifaximin—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00612	0.00766	CcSEcCtD
Rifaximin—Body temperature increased—Levothyroxine—hypothyroidism	0.00612	0.00766	CcSEcCtD
Rifaximin—Chest pain—Liotrix—hypothyroidism	0.00594	0.00743	CcSEcCtD
Rifaximin—Arthralgia—Liotrix—hypothyroidism	0.00594	0.00743	CcSEcCtD
Rifaximin—Confusional state—Liotrix—hypothyroidism	0.00574	0.00718	CcSEcCtD
Rifaximin—Anaphylactic shock—Liotrix—hypothyroidism	0.0057	0.00712	CcSEcCtD
Rifaximin—Infection—Liotrix—hypothyroidism	0.00566	0.00708	CcSEcCtD
Rifaximin—Shock—Liotrix—hypothyroidism	0.00561	0.00701	CcSEcCtD
Rifaximin—Asthenia—Levothyroxine—hypothyroidism	0.00556	0.00695	CcSEcCtD
Rifaximin—Asthenia—Dextrothyroxine—hypothyroidism	0.00556	0.00695	CcSEcCtD
Rifaximin—Hyperhidrosis—Liotrix—hypothyroidism	0.00551	0.00689	CcSEcCtD
Rifaximin—Pruritus—Dextrothyroxine—hypothyroidism	0.00548	0.00685	CcSEcCtD
Rifaximin—Pruritus—Levothyroxine—hypothyroidism	0.00548	0.00685	CcSEcCtD
Rifaximin—Anorexia—Liotrix—hypothyroidism	0.00543	0.00679	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—ZNF764—hypothyroidism	0.00539	0.0269	CbGpPWpGaD
Rifaximin—Hypotension—Liotrix—hypothyroidism	0.00532	0.00666	CcSEcCtD
Rifaximin—Diarrhoea—Levothyroxine—hypothyroidism	0.0053	0.00663	CcSEcCtD
Rifaximin—Diarrhoea—Dextrothyroxine—hypothyroidism	0.0053	0.00663	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.00519	0.00649	CcSEcCtD
Rifaximin—Insomnia—Liotrix—hypothyroidism	0.00515	0.00644	CcSEcCtD
Rifaximin—NR1I2—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.00514	0.0257	CbGpPWpGaD
Rifaximin—Dyspnoea—Liotrix—hypothyroidism	0.00508	0.00635	CcSEcCtD
Rifaximin—Decreased appetite—Liotrix—hypothyroidism	0.00495	0.00619	CcSEcCtD
Rifaximin—Vomiting—Dextrothyroxine—hypothyroidism	0.00492	0.00616	CcSEcCtD
Rifaximin—Vomiting—Levothyroxine—hypothyroidism	0.00492	0.00616	CcSEcCtD
Rifaximin—Fatigue—Liotrix—hypothyroidism	0.00491	0.00614	CcSEcCtD
Rifaximin—Rash—Dextrothyroxine—hypothyroidism	0.00488	0.00611	CcSEcCtD
Rifaximin—Rash—Levothyroxine—hypothyroidism	0.00488	0.00611	CcSEcCtD
Rifaximin—Dermatitis—Dextrothyroxine—hypothyroidism	0.00488	0.0061	CcSEcCtD
Rifaximin—Dermatitis—Levothyroxine—hypothyroidism	0.00488	0.0061	CcSEcCtD
Rifaximin—Constipation—Liotrix—hypothyroidism	0.00487	0.00609	CcSEcCtD
Rifaximin—Headache—Dextrothyroxine—hypothyroidism	0.00485	0.00607	CcSEcCtD
Rifaximin—Headache—Levothyroxine—hypothyroidism	0.00485	0.00607	CcSEcCtD
Rifaximin—Feeling abnormal—Liotrix—hypothyroidism	0.00469	0.00587	CcSEcCtD
Rifaximin—Gastrointestinal pain—Liotrix—hypothyroidism	0.00466	0.00582	CcSEcCtD
Rifaximin—NR1I2—Generic Transcription Pathway—THRB—hypothyroidism	0.00465	0.0232	CbGpPWpGaD
Rifaximin—Nausea—Levothyroxine—hypothyroidism	0.0046	0.00575	CcSEcCtD
Rifaximin—Nausea—Dextrothyroxine—hypothyroidism	0.0046	0.00575	CcSEcCtD
Rifaximin—Urticaria—Liotrix—hypothyroidism	0.00453	0.00566	CcSEcCtD
Rifaximin—Abdominal pain—Liotrix—hypothyroidism	0.0045	0.00563	CcSEcCtD
Rifaximin—Body temperature increased—Liotrix—hypothyroidism	0.0045	0.00563	CcSEcCtD
Rifaximin—Hypersensitivity—Liotrix—hypothyroidism	0.0042	0.00525	CcSEcCtD
Rifaximin—Asthenia—Liotrix—hypothyroidism	0.00409	0.00511	CcSEcCtD
Rifaximin—Pruritus—Liotrix—hypothyroidism	0.00403	0.00504	CcSEcCtD
Rifaximin—Diarrhoea—Liotrix—hypothyroidism	0.0039	0.00487	CcSEcCtD
Rifaximin—Dizziness—Liotrix—hypothyroidism	0.00377	0.00471	CcSEcCtD
Rifaximin—Vomiting—Liotrix—hypothyroidism	0.00362	0.00453	CcSEcCtD
Rifaximin—Rash—Liotrix—hypothyroidism	0.00359	0.00449	CcSEcCtD
Rifaximin—Dermatitis—Liotrix—hypothyroidism	0.00359	0.00449	CcSEcCtD
Rifaximin—Headache—Liotrix—hypothyroidism	0.00357	0.00446	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—THRA—hypothyroidism	0.00347	0.0173	CbGpPWpGaD
Rifaximin—Nausea—Liotrix—hypothyroidism	0.00338	0.00423	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—NKX2-5—hypothyroidism	0.00247	0.0124	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—THRB—hypothyroidism	0.00224	0.0112	CbGpPWpGaD
Rifaximin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000723	0.00361	CbGpPWpGaD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000586	0.00293	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—IYD—hypothyroidism	0.000367	0.00183	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ATP5O—hypothyroidism	0.000312	0.00156	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—POMC—hypothyroidism	0.000311	0.00155	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—TPO—hypothyroidism	0.000293	0.00147	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—TSHB—hypothyroidism	0.000136	0.000679	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	0.000121	0.000605	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—SLC5A5—hypothyroidism	0.000102	0.000508	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—POMC—hypothyroidism	5.32e-05	0.000266	CbGpPWpGaD
